Philips StentBoost Live R2.0 application, when used with the Philips Azurion with software relea...

FDA Device Recall #Z-0737-2022 — Class II — February 2, 2022

Recall Summary

Recall Number Z-0737-2022
Classification Class II — Moderate risk
Date Initiated February 2, 2022
Status Terminated
Voluntary FDA Mandated

Recalling Firm

Firm Philips Healthcare
Location Andover, MA
Product Type Devices
Quantity 42 Systems

Product Description

Philips StentBoost Live R2.0 application, when used with the Philips Azurion with software release R2.x

Reason for Recall

Due to an incorrect configuration setting in the EPX database of StentBoost Live, acquisition does not stop automatically as it should. When the user selects the StentBoost Live protocol on the Philips Azurion system, the following on-screen message is displayed to the user in the Philips StentBoost Live application: "Press the cine pedal until the acquisition stops". However, due to the incorrect configuration of the EPX database, the acquisition does not stop after 40 images, but instead it continues as long as the pedal is pressed.

Distribution Pattern

US Nationwide distribution.

Lot / Code Information

Azurion R2.1

Other Recalls from Philips Healthcare

Recall # Classification Product Date
Z-2520-2023 Class II Incisive CT, software version 5.0 Aug 2, 2023
Z-0238-2022 Class II Philips Azurion systems with software releases ... Sep 24, 2021
Z-0241-2022 Class II CombiDiagnost R90 is multi-functional general R... Sep 22, 2021
Z-0240-2022 Class II ProxiDiagnost N90 is multi-functional general R... Sep 22, 2021
Z-0239-2022 Class II DigitalDiagnost C90 Sep 22, 2021

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.